Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Pipefy today announced its generative AI workflow automation solution that enables uers to build, automate, and optimize workflows faster
-
Announced positive survival data from the phase 2 randomized controlled clinical trial of CAN-2409 in borderline resectable pancreatic cancerPresented positive topline overall survival data from the...
-
Dublin, Aug. 13, 2024 (GLOBE NEWSWIRE) -- The "Petroleum Industry in South Africa 2024" report has been added to ResearchAndMarkets.com's offering. This report on the petroleum industry in South...
-
Phase 2b ASCEND trial top-line data remains on track to be reported in fourth quarter of 2024 Available cash projected to fund current operations into early 2026 and all active studies through to...
-
SANTA CLARA, Calif., Aug. 12, 2024 (GLOBE NEWSWIRE) -- AMD (NASDAQ: AMD) today announced the completion of its acquisition of Silo AI, the largest private AI lab in Europe. The all-cash transaction...
-
TORONTO, Aug. 12, 2024 (GLOBE NEWSWIRE) -- TitanFile, a leader in secure file sharing and collaboration, announced today that it has worked with Microsoft and NetDocuments to bring new tools and...
-
New York, United States , Aug. 10, 2024 (GLOBE NEWSWIRE) -- The Global Wind Speed and Direction Sensor Market Size is to hold a significant share by 2033, at a Compound Annual Growth Rate (CAGR) of...
-
New York, United States , Aug. 09, 2024 (GLOBE NEWSWIRE) -- The Global Refurbished PC Market Size is to Grow from USD 11351 Million in 2023 to USD 21321 Million by 2033, at a Compound Annual Growth...
-
New York, United States , Aug. 09, 2024 (GLOBE NEWSWIRE) -- The Global Sound Level Meters Market Size is to Grow from USD 1.15 Billion in 2023 to USD 2.03 Billion by 2033, at a Compound Annual...
-
- Initial readout from first-line RAS-mut. mCRC randomized CRDF-004 trial expected in 2H 2024 - - Published preclinical data underscores the ability of onvansertib to overcome resistance to PARP...